| Literature DB >> 34064647 |
Karl J Schreiber1, Ilea J Chau-Ly1, Jennifer D Lewis1,2.
Abstract
Phytopathogenic bacteria possess an arsenal of effector proteins that enable them to subvert host recognition and manipulate the host to promote pathogen fitness. The type III secretion system (T3SS) delivers type III-secreted effector proteins (T3SEs) from bacterial pathogens such as Pseudomonas syringae, Ralstonia solanacearum, and various Xanthomonas species. These T3SEs interact with and modify a range of intracellular host targets to alter their activity and thereby attenuate host immune signaling. Pathogens have evolved T3SEs with diverse biochemical activities, which can be difficult to predict in the absence of structural data. Interestingly, several T3SEs are activated following injection into the host cell. Here, we review T3SEs with documented enzymatic activities, as well as T3SEs that facilitate virulence-promoting processes either indirectly or through non-enzymatic mechanisms. We discuss the mechanisms by which T3SEs are activated in the cell, as well as how T3SEs modify host targets to promote virulence or trigger immunity. These mechanisms may suggest common enzymatic activities and convergent targets that could be manipulated to protect crop plants from infection.Entities:
Keywords: Pseudomonas syringae; Ralstonia; Xanthomonas; biochemical activity; effector-triggered immunity; host activation; host targets; type III secreted effector; virulence promotion
Year: 2021 PMID: 34064647 PMCID: PMC8150971 DOI: 10.3390/microorganisms9051029
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Schematic overview of bacterial type III-secreted effector (T3SE) activities in the plant intracellular space. The T3SEs discussed in this review are arranged in functional categories based on their characterized target(s) in terms of biological process or subcellular location. For each T3SE, a black border indicates that the T3SE negatively regulates its target in some manner, while T3SEs with a green border function as positive regulators. Note that the GALA family of T3SEs interacts with several target proteins that are primarily nuclear-localized but may be found in other subcellular locations as well. Limited data are available for the localization of AvrE-type T3SEs, but AvrE1 is known to associate with the plasma membrane.
Summary of biochemical activities and (a)virulence functions of type III-secreted effector proteins from phytopathogenic bacteria.
| Activity | Effector | Pathogen | Host Target(s)/Substrate(s) | Consequences of Activity for Pathogen Virulence/Avirulence | Ref. | |
|---|---|---|---|---|---|---|
| Acetyltransferase | AvrBsT |
| Phosphorylation | ACIP1 | Suppresses PTI and ETI; acetylated ACIP1 forms aggregates whose association with microtubules may be altered | [ |
| Unknown | Suppresses AvrBs1-mediated ETI in a SnRK1-dependent manner | [ | ||||
| HopZ1a |
| Myristoylation, phytate binding | Tubulin | Decreases microtubule networks, disrupts secretory pathways, and suppresses cell wall-based immunity | [ | |
| JAZ proteins | Promotes degradation of JAZ proteins and activates JA signaling, acetylation not shown | [ | ||||
| ZED1 | Activates ZAR1-mediated ETI | [ | ||||
| HopZ3 |
| Phytate binding | AvrB, AvrRpm1, RIN4, RIPK | Suppresses RPM1-mediated ETI | [ | |
| PopP2 |
| Phytate binding | WRKY proteins | Prevents WRKY proteins from binding DNA and activating immunity genes | [ | |
| RRS1 | Activates RRS1/RPS4-mediated ETI | [ | ||||
| ADP-ribosyltransferase | AvrRpm1 |
| Myristoylation/Palmitoylation | RIN4 | Promotes RIN4 phosphorylation, which enhances associations between RIN4 and exocyst subunits and dampens flg22-induced callose deposition; activates RPM1-mediated ETI | [ |
| HopF2 |
| Myristoylation | RIN4 | Inhibits proteolytic cleavage of RIN4 by AvrRpt2 to prevent AvrRpt2-induced ETI | [ | |
| MKK4, MKK5 | Disrupts MAP kinase cascade to block PTI | [ | ||||
| BAK1 | Inhibits multiple downstream signaling events, including the phosphorylation of BIK1 and MAPKs, to block PTI | [ | ||||
| HopO1-1 1 |
| Myristoylation | PDLP7 | Destabilizes PDLP7 to increase plasmodesmata-mediated molecular flow and enhance bacterial spread within tissues | [ | |
| (HopO1 allele) | Unknown | Activates ZAR1-mediated ETI | [ | |||
| HopU1 |
| --- | GRP7 | Interferes with GRP7 binding to PRR transcripts, thus reducing PTI | [ | |
| Cysteine protease | AvrPphB |
| Myristoylation/Palmitoylation | BIK1 and other PBS1-like protein kinases | Suppresses PTI | [ |
| RIPK | Blocks the recognition of AvrB by RPM1 | [ | ||||
| PBS1 | Activates RPS5-mediated ETI | [ | ||||
| AvrRpt2 |
| Folding assisted by host cyclophilin ROC1 | RIN4 | Activates RPS2-mediated ETI, but suppresses PTI in plants lacking RPS2; blocks recognition of AvrRpm1 and AvrB by RPM1 | [ | |
| HopN1 |
| --- | PsbQ | Reduces pathogen-induced ROS production and necrotic disease symptoms | [ | |
| HopX1 |
| --- | JAZ proteins | Enhances JA signaling, repressing SA signaling and promoting susceptibility to (hemi)biotrophic pathogens | [ | |
| HopZ4 |
| Myristoylation | RPT6, proteasome | Inhibits proteasome activity | [ | |
| RipE1 |
| --- | JAZ proteins | Enhances JA signaling, repressing SA signaling and promoting susceptibility to (hemi)biotrophic pathogens | [ | |
| XopJ |
| Myristoylation | RPT6, proteasome | Inhibits and degrades RPT6, suppresses cell wall-based immunity and SA signaling | [ | |
| SUMO protease | AvrXv4 |
| --- | Unknown | Elicits a hypersensitive response in | [ |
| XopD |
| --- | SlERF4 | Destabilizes SlERF4 and suppresses ethylene-mediated defense responses | [ | |
| Threonine protease | HopB1 |
| --- | BAK1 | Suppresses PTI | [ |
| Protein kinase | AvrRxo1 | Myristoylation | NAD | Production of 3′-NADP (uncharacterized mechanism of virulence promotion) | [ | |
| SINAT4 | Enhances degradation of RD21A which suppresses drought-induced immunity | [ | ||||
| HopBF1 |
| --- | Hsp90 | Inactivates Hsp90 to destabilize NLRs and dampen ETI; may also promote cell death during the necrotrophic phase of | [ | |
| XopAU |
| --- | MKK2 | Activates MKK2 to manipulate MAPK signaling and promote chlorosis | [ | |
| Phosphothreonine lyase | HopAI1 |
| --- | MPK3, MPK6 | Disrupts MAPK signaling cascade and suppresses PTI | [ |
| MPK4 | Activates SUMM2-mediated ETI | [ | ||||
| Tyrosine phosphatase | HopAO1 |
| --- | EFR, LORE, and possibly FLS2 | Suppresses PTI | [ |
| Ubiquitin–proteasome machinery | AvrPtoB |
| Phosphorylation/Ubiquitination | EFR, FLS2, BAK1, CERK1 | Degrades PRRs to suppress PTI | [ |
| NPR1 | Degrades NPR1 to disrupt SA-mediated signaling and SAR | [ | ||||
| Fen | Degrades Fen to block AvrPtoB-mediated ETI | [ | ||||
| Pto | Activates Pto/Prf-mediated ETI (Pto is neither ubiquitinated nor degraded) | [ | ||||
| GALA proteins |
| --- | SKP1-like proteins | Promotes virulence via an unknown mechanism | [ | |
| RipAR |
| --- | Unknown | Suppresses PTI | [ | |
| RipAW |
| --- | Unknown | Suppresses PTI | [ | |
| RipV2 |
| --- | Unknown | Suppresses PTI | [ | |
| XopAE |
| --- | Unknown | Suppresses PTI | [ | |
| XopI | --- | OsTrxh2 | Degradation of OsTrxh2 represses OsNPR-mediated signaling and SAR | [ | ||
| XopK | --- | OsSERK2 | Virulence promotion | [ | ||
| XopL |
| --- | SH3P2 | Suppresses PTI and promotes virulence by inhibiting autophagy | [ | |
| Uridylyltransferase | AvrAC | --- | BIK1, RIPK | Suppresses PTI and RPM1-mediated ETI | [ | |
| PBL2 | Activates ZAR1-mediated ETI | [ | ||||
| Phytase/Phosphatase | XopH |
| --- | Phytate | Suppresses PTI, activates Bs7-mediated ETI | [ |
| Trehalose phosphate synthase | RipTps |
| --- | Glucose-6-phosphate | Promotes trehalose synthesis (uncharacterized impact on virulence) | [ |
| Gamma-glutamyl cyclo-transferase | RipAY |
| Thioredoxin binding | Glutathione | Suppresses PTI | [ |
| Nudix hydrolase | RipN |
| --- | ADP-ribose, NADH | Suppresses PTI | [ |
| Nucleoside hydrolase | HopQ1 |
| Phosphorylation | Cytokinin precursors | Increases cytokinin accumulation to suppress PTI | [ |
| XopQ | Phosphorylation | Natural substrate unknown | Contributes to pathogen virulence, although the role of nucleoside hydrolase activity is unknown | [ | ||
| Deamidase (predicted) | HopAF1 |
| Myristoylation/Palmitoylation | MTN1, MTN2 | Inhibits MTN activity to reduce ethylene biosynthesis and suppress PTI | [ |
| Lipase (predicted) | RipAL |
| --- | Chloroplast lipids (predicted) | Stimulates JA biosynthesis, repressing SA signaling and promoting susceptibility to (hemi)biotrophic pathogens | [ |
| Indirect/Non-enzymatic mechanisms | AvrB |
| Phosphorylation/Myristoylation | RIPK and other RLCKs | Enhances kinase activity to phosphorylate RIN4 and suppress PTI; can trigger ETI through RPM1 | [ |
| MPK4 | Upregulates jasmonate signaling to enhance pathogen susceptibility | [ | ||||
| AvrBsT |
| Phosphorylation | SGT1 homologs | Activates AvrBsT-mediated ETI | [ | |
| AvrE-type T3SEs | --- | PP2A B’ subunits | Enhances phosphatase activity, which may disrupt sphingolipid biosynthesis | [ | ||
| AvrPto |
| Phosphorylation/Myristoylation/Palmitoylation | FLS2, EFR, CERK1, BAK1/SERK3 | Suppresses PTI | [ | |
| Pto | Activates Pto/Prf-mediated ETI | [ | ||||
| SOBIR1 | Suppresses Cf-4-mediated ETI | [ | ||||
| AvrRpm1 |
| Myristoylation/Palmitoylation | RIPK and other RLCKs | Enhances kinase acitivity to phosphorylate RIN4 and suppress PTI; activates RPM1-mediated ETI | [ | |
| AvrRps4 |
| Host-mediated proteolytic cleavage | BTS | Enhances apoplastic iron accumulation to promote pathogen proliferation | [ | |
| RRS1 | Activates RRS1/RPS4-mediated ETI | [ | ||||
| AvrRpt2 |
| Folding assisted by host cyclophilin ROC1 | Aux/IAA proteins, e.g., AXR2, AXR3 | Enhances auxin signaling to promote susceptibility to infection | [ | |
| AvrRxv |
| --- | ARI1 (14-3-3 protein) | Activates AvrRxv-mediated ETI | [ | |
| HopBB1 |
| --- | TCP14, JAZ3 | Colocalizes TCP14 and JAZ3 for SCFCOI1-dependent degradation, de-repressing JA signaling and suppressing SA signaling | [ | |
| HopE1 |
| Calmodulin binding | MAP65 | Sequesters MAP65 away from the microtubule network, inhibits extracellular secretion of PR-1 | [ | |
| HopG1 |
| --- | Kinesin | Promotes actin filament bundling and enhances symptom development; suppression of PTI | [ | |
| HopI1 |
| --- | Hsp70 | Hsp70 is recruited to chloroplasts and forms a complex that suppresses defense responses | [ | |
| HopM1 |
| --- | AtMIN7 | Facilitates AtMIN7 degradation to suppress PTI and ETI | [ | |
| HopQ1 |
| Phosphorylation | 14-3-3 proteins | Suppresses PTI | [ | |
| HopW1 |
| --- | Actin | Promotes virulence by disrupting actin filaments | [ | |
| RipAC |
| --- | SGT1 homologs | Disrupts SGT1–RAR1 interactions and blocks SGT1 phosphorylation to suppress ETI | [ | |
| PUB4 | Blocks PUB4 E3 ubiquitin ligase activity to suppress PTI | [ | ||||
| RipAK |
| --- | Catalases | Interacts with and inhibits catalases to interfere with reactive oxygen species-mediated signaling | [ | |
| TAL effectors | --- | DNA, often at gene promoters | Manipulate host gene expression to promote pathogen growth; may elicit ETI in specific host genetic backgrounds | Reviewed in [ | ||
| XopN |
| Phosphorylation | TARK1, 14-3-3 proteins (e.g., TFT1) | Acts as a scaffold for TFT1–TARK1 interactions to suppress PTI | [ | |
| XopP |
| --- | OsPUB44 | Blocks OsPUB44 E3 ubiquitin ligase activity to suppress PTI | [ | |
| XopQ | Phosphorylation | 14-3-3 proteins | Suppresses ETI (tomato) and PTI (rice) | [ | ||
| ROQ1 | Activates ROQ1-mediated ETI | [ | ||||
| XopX |
| Phosphorylation | 14-3-3 proteins | Suppresses PTI | [ |
1 ADP-ribosylation activity of HopO1-1 is inferred but not directly demonstrated.